Quick Answer
Dyne Therapeutics, Inc. reported Long Term Debt of $148.92 million for the year ending 2025.
- This data is from Dyne Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $9.94 million | Q2 2025: $98.81 million | Q3 2025: $99.15 million.
- Historical annual values: Fiscal year 2025: $148.92 million | Fiscal year 2024: $0.00.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: